0001179110-17-000380.txt : 20170104 0001179110-17-000380.hdr.sgml : 20170104 20170104191600 ACCESSION NUMBER: 0001179110-17-000380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161230 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelossof Avi CENTRAL INDEX KEY: 0001293460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 17508029 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 4 1 edgar.xml FORM 4 - X0306 4 2016-12-30 0 0001145460 ALERE INC. ALR 0001293460 Pelossof Avi 51 SAWYER ROAD, SUITE 200 WALTHAM MA 02453 0 1 0 0 GlobalPres, Infectious Disease Common Stock 2016-12-30 4 M 0 20000 38.70 A 35524 D Common Stock 2016-12-30 4 F 0 19903 39 D 15621 D Common Stock 2016-12-30 4 M 0 9668 38.70 A 25289 D Common Stock 2016-12-30 4 F 0 9627 38.96 D 15662 D Common Stock 2016-12-30 4 M 0 10332 38.70 A 25994 D Common Stock 2016-12-30 4 F 0 10263 38.96 D 15731 D Employee Stock Option (right to buy) 38.70 2016-12-30 4 M 0 20000 D 2017-01-01 Common Stock 20000 9668 D Employee Stock Option (right to buy) 38.70 2016-12-30 4 M 0 9668 D 2017-01-01 Common Stock 9668 0 D Employee Stock Option (right to buy) 38.70 2016-12-30 4 M 0 10332 D 2017-01-01 Common Stock 10332 0 D These options became exercisable in four equal annual installments beginning January 1, 2007. This derivative security does not have a price. Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above. The Options were scheduled to expire on January 1, 2017. /s/ Douglas Barry, Attorney-in-Fact 2017-01-04